Fluidai.md – AI-Powered Postoperative Monitor Stream™ Platform continuously and non-invasively analyzes postoperative wound drainage. Measurements from Stream™ Platform may prompt earlier intervention as per current standard of care.
Leveraging advanced sensors and an AI-driven algorithm, the non-invasive device helps in the early detection of leaks.
It features the Origin Inline Device that collects patient data from the surgical site, as well as the Delta Bedside Monitor tablet, which analyses and shows patient data using the Stream app.
It features the Origin Inline Device that collects patient data from the surgical site, as well as the Delta Bedside Monitor tablet, which analyses and shows patient data using the Stream app.
The new easy-to-use platform uses patient-specific data for enhancing postoperative care.
Origin™ measurements are used to calculate a patient’s Anastomotic Leak Risk on the Delta™ monitor. This score is a real-time indication based on Origin™’s continuous measurements of whether the patient is at risk of developing an anastomotic leak.
Through the use of the Stream™ Platform, surgeons have the potential to make a more accurate and timely diagnosis of postoperative leaks, dreaded complications of digestive tract surgeries, which can lead to better treatment outcomes and an improved quality of life for their patients. Stream™ Platform’s international debut, made possible through the company’s strategic partnerships with Canadian Hospital Specialties Limited (CHS Ltd.) and Gulf Medical Co. Ltd., marks an exciting new chapter in postoperative care around the world.
“The launch of Stream™ Platform is a pivotal milestone in addressing the critical need we hear from surgeons across the globe: patients suffer from life-threatening complications, and we don’t catch them soon enough. With a data-driven approach backed by artificial intelligence, we can predict complications and enable preventative medicine – an entirely new paradigm of care that is precise and tailored to individual patient needs.”
– Youssef Helwa, CEO and Cofounder of FluidAI
About Stream™ Platform
Postoperative leaks are a potential complication for patients who have undergone gastrointestinal surgery. Leaks are a significant concern, carrying a high risk of morbidity and mortality for patients, potential short- and long-term consequences, and significant implications for healthcare systems more broadly, including increased length of patient stay and decreased quality of life.
The Stream™ Platform is a system that utilises patient-specific data to improve postoperative care. Using advanced sensors and an AI-driven algorithm, this non-invasive, easy-to-use device, can help drive detection of leaks early on, which can ultimately save hospitals both time and money.
The Stream™ Platform consists of the Origin™ Inline Device, which gathers patient data from the surgical site; and the Delta™ Bedside Monitor, a tablet that utilizes the Stream™ app to analyze and display the patient data.
About FluidAI Medical
FluidAI (formerly known as NERv Technology Inc.) is a Canadian medical technology company that uses AI to aid with the early detection of postoperative leaks. From general to gastrointestinal surgeries, FluidAI’s mission is to empower healthcare providers with data-driven solutions that improve patient outcomes and advance postoperative care. To learn more about FluidAI and how the company is transforming postoperative care, please visit https://fluidai.md/.
For further information: Mustafa Obeidat, Strategic Partnerships, FluidAI Medical, +1 (877) 660-6378 ex. 205, [email protected]